We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00002988
Recruitment Status : Completed
First Posted : May 19, 2004
Last Update Posted : June 20, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Duke University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2000
  Study Completion Date : November 2000